catégorie
Xihong Biopharma Grants Exclusive License to CMS for Injectable PLLA Filler
The injectable poly-L-lactic acid (PLLA) microsphere filler is classified as a Class III medical device and is currently undergoing registrational clinical trials in China. The product utilizes a patented microsphere fabrication process, resulting in uniformly shaped microspheres with even subcutaneous distribution and outstanding clinical performance.
Jul 10th,2025
217 Vues
